Forlax is an osmotic laxative. Indications for use - symptomatic treatment of constipation in children aged 6 months to 8 years.
Warehouse
1 sachet contains macrogol 4000 4 g; excipients: orange-grapefruit flavoring (orange and grapefruit essential oils, concentrated orange juice, citral, acetaldehyde, linalool, ethyl butyrate, alpha-terpineol, octanal, beta- and gamma-hexenol, maltodextrin, acacia gum (E 414), sorbitol (E 420), butylhydroxyanisole (E 320) and sulfur dioxide (E 220)); sodium saccharin.
Contraindication
severe inflammatory bowel disease (e.g. ulcerative colitis, Crohn's disease) or toxic megacolon: perforation or risk of perforation of the gastrointestinal tract; ileus or suspected intestinal obstruction, symptomatic stenosis; abdominal pain syndromes of undetermined origin; hypersensitivity to the active substance or to any of the excipients of the medicinal product.
Method of application
For oral use.
Doses for children aged:
from 6 months to 1 year: 1 sachet (4 g) per day.
from 1 to 4 years: 1–2 sachets (4–8 g) per day.
from 4 to 8 years: 2–4 sachets (8–16 g) per day.
The daily dose is determined according to the expected clinical effect.
The first effect of using the drug FORLAX® occurs within 24–48 hours after administration.
Application features
Before starting treatment, the doctor must make sure that there are no organic disorders, especially in patients under 2 years of age. FORLAX® (4 g) is prescribed for the temporary treatment of constipation as an adjunct, provided that appropriate sanitary and hygienic recommendations and diet are followed; the maximum duration of the course of treatment is 3 months. If the symptoms do not disappear despite dietary recommendations, the root cause must be identified and eliminated.
Reservation
Data on the effectiveness of use in children under 2 years of age were obtained in a limited number of patients.
Treatment of constipation with any medication is only an adjunctive therapy that involves adhering to a healthy lifestyle and eating habits, namely:
consuming more fluids and dietary fiber; maintaining adequate physical activity and restoring bowel function.
Before starting treatment, it is necessary to make sure that there are no organic disorders.
After a 3-month course of treatment, it is advisable to conduct a complete clinical examination for constipation.
Pregnant women
Animal studies do not indicate direct or indirect toxic effects on reproductive function.
Data on the use of FORLAX® in pregnant women are limited (less than 300 pregnancy outcomes).
No effect during pregnancy is expected, as the systemic exposure of FORLAX® is insignificant. FORLAX® can be used during pregnancy.
Children
The duration of treatment for children should not exceed 3 months due to the lack of clinical trial data on the use of this medicinal product for more than 3 months. The restoration of intestinal motility as a result of treatment should be supported by adherence to hygiene and dietary recommendations.
Drivers
Not installed.
Overdose
Diarrhea, abdominal pain, and vomiting have been reported. Diarrhea caused by taking an excessive dose of this drug will resolve if treatment is temporarily stopped or the dose is reduced.
Excessive fluid loss due to diarrhea or vomiting may require correction of electrolyte imbalances.
Side effects
On the part of the digestive system - urgent urge to defecate, involuntary bowel movements.
Metabolism and nutrition - disturbances of water and electrolyte balance (hyponatremia, hypokalemia) and/or dehydration, especially in elderly patients.
On the part of the immune system - erythema.
Storage conditions
The medicine does not require any special storage conditions. Keep out of the reach of children.
